ropeginterferon alfa-2b

Italy

Drugs containing this active substance

  • BESREMI

    It is used as monotherapy for the treatment of polycythemia vera in adults, a condition in which the bone marrow produces an excess of red blood cells, white blood cells, and platelets.

    Form: solution for injection

    Active substance Dosage
    ropeginterferon alfa-2b -

    ATC: L03AB15

    Manufacturer: AOP ORPHAN PHARMACEUTICALS gmbh